Biotech

Cleveland BioLabs Announces Expansion of Entolimod Patent Portfolio With New Composition of Matter Patents

BUFFALO, NY: ...

BioCell Labs Initiates Product Development

VANCOUVER, BRITISH COLUMBIA: ...

Theravance Biopharma Initiates Patient Registry Study for VIBATIV(R) (telavancin)

GEORGE TOWN, GRAND CAYMAN: First Patient Enrolled in Telavancin Observational Use Registry (TOUR); Large-Scale Study to Create Knowledge Base to Guide Optimal Clinical Use and Future Development of VIBATIV(R) ...

TapImmune''s CEO Says Company Is Preparing "A Very Deep Pipeline in Multiple Indications" for Phase II Trials

LOS ANGELES, CA: ...

Newly Presented Data Shows That Peregrine Pharmaceuticals'' PS-Targeting Antibodies Significantly Enhance Anti-Tumor Activity of Immune Checkpoint Inhibitors PD-1 and CTLA-4 in Models of Breast Cancer and Melanoma

TUSTIN, CA: PS-Targeting Antibodies Block Tumor Suppression of Immune System Allowing Development of Robust Immune Responses Resulting in Statistically Significant Improvement in Anti-Tumor Activity; Specific Eff ...

Dynavax Announces Laura Brege Has Joined Board of Directors and Denise Gilbert Will Retire

BERKELEY, CA: ...

Ceapro Raises an Additional $310,000 Through a Non-Brokered Private Placement

EDMONTON, ALBERTA: ...

Horizon Pharma plc Announces Issuance of VIMOVO(R) Related Patent with Protection to 2031 from United States Patent and Trademark Office

DUBLIN, IRELAND: ...

Abattis Seeks Financing Solutions to Facilitate New Growth Initiative: Abattis Ends US$5 Million Standby Equity Purchase Agreement With Kodiak Capital Group LLC

VANCOUVER, BRITISH COLUMBIA: ...

iBio Adds to iBioModulator Portfolio and Product Pipeline

NEWARK, DE: ...